Navigation Links
Asymchem Announces Opening of High Potency API and Drug Product Facility

Facility Open as of May 1st, 2009 in TEDA Tianjin, China

TEDA Tianjin, China, May 20 /PRNewswire/ -- Asymchem Laboratories, Inc., a leading research-based contract manufacturer of API's and intermediates, and Drug Products to the pharmaceutical industry, is pleased to announce the opening if its high potency Active Pharmaceutical Ingredient (API) and Drug Product facility in TEDA Tianjin, China.

This dedicated facility is sited at Asymchem's TEDA Tianjin 1 location, and provides state-of-the art containment for production of potent API's, as well as tablet and capsule manufacturing that incorporate potent ingredients. The new facility allows Asymchem to operate two separate API manufacturing trains of 50 and 100L, as well as additional facilities for smaller-scale research and production and oral dosage form manufacturing.

"We are pleased to expand our capabilities in process research and manufacturing into the potent compound arena, and provide our partners with cost-effective and quality-driven means for undertaking this type of work in China," states Dr. Hao Hong, CEO of Asymchem.

Asymchem seeks to be a leader among Chinese-located manufacturing operations not only in facility design but also worker safety, and the Tianjin potent compound site was designed and validated by recognized and accredited experts in the potent compound community. As one of the largest and most respected pharmaceutical manufacturers in China, Asymchem is pleased to extend its broad range of API and drug product capabilities to this exciting and rapidly emerging field of drug research and development.

Asymchem Laboratories is a leading research-based contract manufacturer specialized in the development and compliant manufacturing (Contract Research and Manufacturing Services) of API's and Drug Products serving the pharmaceutical industry. With a 14-yr track record, Asymchem is committed to the highest level of quality and excellence in the integrated CMC services arena. For further information, please visit the Asymchem website at

SOURCE Asymchem Laboratories
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. TrinityCare Senior Living, Inc. Announces First Quarter Operating Results
2. SXC Health Solutions announces agreements for pharmacy technology services with Prime Therapeutics LLC
3. Recondo Technology Announces Two New Board Members
4. Families of Spinal Muscular Atrophy Announces its New Medical Advisory Council
5. Cornerstone Therapeutics Announces Management Change
6. 3SBio Inc. Announces Unaudited First Quarter 2009 Results
7. Volcano Announces OCT Activities at EuroPCR 2009
8. International Isotopes Inc. Announces First Quarter 2009 Financial Results
9. LodgeNet Healthcare Announces Deployment of Interactive Patient Television System in Oklahoma Heart Hospital
10. Arcadia Resources Announces Sale of Non-Strategic Businesses
11. Fred A. Baughman Jr., MD Announces: Vets Sudden Cardiac Deaths Are Not Suicides or Overdoses
Post Your Comments:
(Date:6/27/2016)... ... ... recently awarded their highest five-star rating to Best Buy Eyeglasses, an ... United States and Canada wear eyeglasses. Once considered to be a purely functional part ... fashion statement. Even celebrities use glasses as a way of creating an iconic image—like ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 26, 2016 One of Australia,s ... announced the formation of a new biotechnology company, Noxopharm Limited [ABN ... in an IPO and to list on the ASX. ... NOX66, ready to enter a Phase 1 clinical study later this ... to address one of the biggest problems facing cancer patients - ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals plc ... period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, ... of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ... (Eastern Daylight Time). As previously announced on ... a definitive merger agreement under which Jazz Pharmaceuticals has ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology: